Proxy Results Form 8 K

Item 5.07 Submission of Matters to a Vote of Security Holders.

On October 25, 2024, Aptevo Therapeutics Inc. (the "Company") held its 2024 Special Meeting of Stockholders (the "Special Meeting"), at which a quorum was present. Stockholders considered three proposals outlined below, each of which is described in more detail in the Company's definitive proxy statement for the Special Meeting filed with the Securities and Exchange Commission on October 3, 2024 (the "Proxy Statement"). The final voting results with respect to each of the proposals acted upon at the 2024 Special Meeting are set forth below.

Proposal 1: Approval of the stock issuance and warrant proposal

The issuance of more than 19.99% of the Company's outstanding Common Stock, issuable upon the exercise of Common Warrants issued pursuant to that certain Securities Purchase Agreement, dated as of September 16, 2024, which includes an exercise price adjustment provision in the event of an issuance of common stock or common stock equivalent, an option to purchase common stock or common stock equivalent, change in price of common stock or common stock equivalent or other such event as described in the Common Warrants and to approve the amendment of certain existing warrants to include the same exercise price adjustment provisions and the repricing of such existing warrants pursuant to the Securities Purchase Agreement, was approved based on the following:

FOR		AGAINST		ABSTAIN		BROKER NON-VOTES
593,301		412,901		5,355		2,268,029

Proposal 2: Approval of the Company's Amended and Restated Certificate of Incorporation

An amendment to the Company's Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split of the Company common stock at a ratio in the range of 1-for-5 to 1-for-37, with such ratio to be determined in the discretion of the Board and with such reverse stock split to be effected at such time and date, if at all, as determined by the Board in its sole discretion, was approved based on the following:

FOR		AGAINST		ABSTAIN		BROKER NON-VOTES
1,795,519		1,479,494		4,573		0

Proposal 3: Authorization to adjourn the Special Meeting

The authorization to adjourn the Special Meeting to a later date, if necessary or appropriate, was approved based on the following votes:

FOR		AGAINST		ABSTAIN		BROKER NON-VOTES
2,017,270		1,253,171		9,145		0

Public link

Please use the above public link if you want to share this noodl on another website.